Researchers from MHH and NCI discover cause of rhabdomyosarcoma First study to date to investigate cancer risk in mosaic RASopathies due to disease-causing variants in the HRAS or KRAS genes shows the importance of close cancer surveillance.... weiterlesen
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers www.medrxiv.org/content/10.1101/2024.09.04.24313032v1
Purpose: Molecular markers, such as FOXO1 fusion genes and TP53 and MYOD1 mutations, increasingly in
Today marks the start of #ChildhoodCancerAwarenessMonth#rhabdomyosarcoma for kinder, more effective treatments 100% of money we raise goes to fund research Help us make a difference 🎗️
PAX fusion proteins deregulate gene networks controlling mitochondrial translation in pediatric rhabdomyosarcoma www.biorxiv.org/content/10.1101/2024.07.31.606039v1
Alveolar rhabdomyosarcoma (ARMS) patients harboring PAX3-FOXO1 and PAX7-FOXO1 fusion proteins exhibi
PAX fusion proteins deregulate gene networks controlling mitochondrial translation in pediatric rhabdomyosarcoma www.biorxiv.org/content/10.1101/2024.07.31.606039v1
Alveolar rhabdomyosarcoma (ARMS) patients harboring PAX3-FOXO1 and PAX7-FOXO1 fusion proteins exhibi
Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivo www.biorxiv.org/content/10.1101/2024.07.12.603270v1
Fusion-positive rhabdomyosarcoma is an aggressive pediatric cancer molecularly characterized by arre
Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivo www.biorxiv.org/content/10.1101/2024.07.12.603270v1
Fusion-positive rhabdomyosarcoma is an aggressive pediatric cancer molecularly characterized by arre
Our roadmap for the next generation of Children’s Oncology Group rhabdomyosarcoma trials acsjournals.onlinelibrary.wiley.com/doi/full/10....
<em>Cancer</em> is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
This week, Ben's Dad was delighted to represent Pass The Smile in London the UK's first ever Rhabdomyosarcoma-focussed research strategy-setting day hosted by our friends at Alices Arc and involved some of the UK's leading researchers, clinicians and scientists. Hope. Always hope.
Differential cell-ECM interaction of rhabdomyosarcoma subtypes regulated by PAX3-FOXO1 www.biorxiv.org/content/10.1101/2024.06.11.598505v1
Rhabdomyosarcoma (RMS) is the most common childhood soft tissue sarcoma, with two subtypes: Fusion-p